Medtronic
MDT
2,101 hedge funds and large institutions have $165B invested in Medtronic in 2022 Q1 according to their latest regulatory filings, with 205 funds opening new positions, 1,007 increasing their positions, 672 reducing their positions, and 135 closing their positions.
56% more call options, than puts
Call options by funds: $971M | Put options by funds: $622M
52% more first-time investments, than exits
New positions opened: 205 | Existing positions closed: 135
50% more repeat investments, than reductions
Existing positions increased: 1,007 | Existing positions reduced: 672
48% more capital invested
Capital invested by funds: $112B → $165B (+$53.2B)
8% more funds holding in top 10
Funds holding in top 10: 36 → 39 (+3)
2% more funds holding
Funds holding: 2,060 → 2,101 (+41)
0.24% more ownership
Funds ownership: 80.5% → 80.74% (+0.24%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$782M |
| 2 |
Sumitomo Mitsui Trust Group
Minato-Ku, Tokyo,
Japan
|
+$459M |
| 3 |
Geode Capital Management
Boston,
Massachusetts
|
+$325M |
| 4 |
Franklin Resources
San Mateo,
California
|
+$302M |
| 5 |
Invesco
Atlanta,
Georgia
|
+$295M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$708M |
| 2 |
Massachusetts Financial Services
Boston,
Massachusetts
|
-$432M |
| 3 |
Renaissance Technologies
New York
|
-$370M |
| 4 |
Lazard Asset Management
New York
|
-$350M |
| 5 |
Ninety One (UK)
London,
United Kingdom
|
-$288M |
MDT Hedge Fund Activity: Q1 2022 in Review
2,101 of the 6,340 institutional investors tracked by Wall St. Rank reported a position in Medtronic (MDT) for Q1 2022, worth a combined $165B — up 48% from $112B a quarter earlier.
Buyers outnumbered sellers: 205 funds opened new MDT positions and 135 closed out — a net gain of 70 holders — while 1,007 added to existing stakes and 672 trimmed.
The largest buyer was Vanguard Group, adding an estimated $782M. The largest seller was T. Rowe Price Associates, cutting an estimated $708M.
- 2,101 institutional investors held Medtronic (MDT) as of Q1 2022, up from 2,060 in Q4 2021.
- Funds reported $165B of Medtronic stock for Q1 2022, up 48% quarter-over-quarter.
- 205 funds opened new Medtronic positions in Q1 2022 and 135 closed out, a net change of +70 holders.
- The largest Medtronic buyer in Q1 2022 was Vanguard Group, an estimated $782M added.
- The largest Medtronic seller in Q1 2022 was T. Rowe Price Associates, an estimated $708M sold.
Based on aggregated 13F filings for Q1 2022.